Sushilan Vasoo
Président chez Seacare Education Pte Ltd.
Postes actifs de Sushilan Vasoo
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Seacare Education Pte Ltd. | Président | 10/05/2010 | - |
TauRx Pharmaceuticals Ltd.
 TauRx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology TauRx Pharmaceuticals Ltd. developes drugs and diagnostics for neurodegenerative diseases. its pipeline includes LMTX, a tau aggregation inhibitor (TAI) for Alzheimer?s and Behavioural variant frontotemporal dementia diseases; anti-synuclein, a synuclein protein; early-stage compounds for use in therapies for neurodegenerative diseases; and diagnostic tests that assist clinicians in detecting and confirming the nature of a disease and monitoring the effects of therapy. The company was founded by Claude Wischik in 2002 and is headquartered in Singapore. | Directeur/Membre du Conseil | - | - |
| Singapore Press Holdings Foundation Ltd. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Sushilan Vasoo
Anciens postes connus de Sushilan Vasoo
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ASCENT BRIDGE LIMITED | Directeur/Membre du Conseil | 26/12/2003 | 28/04/2021 |
| Independent Dir/Board Member | 26/12/2003 | 28/04/2021 | |
TauRx Therapeutics Ltd.
 TauRx Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology TauRx Therapeutics Ltd. develops treatments and diagnostics for a range of neurodegenerative diseases. It offers tau aggregation inhibitor, LMTX, a global Phase 3 clinical trials for Alzheimer’s and behavioural-variant Frontotemporal Dementia (bvFTD). LMTXT. The company was founded by Claude Wischik and K M Seng in 2002 and is headquartered in Singapore. | Directeur/Membre du Conseil | 10/05/2010 | - |
Statistiques
Internationale
| Singapour | 6 |
Opérationnelle
| Director/Board Member | 4 |
| Independent Dir/Board Member | 1 |
| Chairman | 1 |
Sectorielle
| Health Technology | 3 |
| Producer Manufacturing | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ASCENT BRIDGE LIMITED | Producer Manufacturing |
| Entreprise privées | 4 |
|---|---|
| Seacare Education Pte Ltd. | |
TauRx Therapeutics Ltd.
TauRx Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology TauRx Therapeutics Ltd. develops treatments and diagnostics for a range of neurodegenerative diseases. It offers tau aggregation inhibitor, LMTX, a global Phase 3 clinical trials for Alzheimer’s and behavioural-variant Frontotemporal Dementia (bvFTD). LMTXT. The company was founded by Claude Wischik and K M Seng in 2002 and is headquartered in Singapore. | Health Technology |
TauRx Pharmaceuticals Ltd.
TauRx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology TauRx Pharmaceuticals Ltd. developes drugs and diagnostics for neurodegenerative diseases. its pipeline includes LMTX, a tau aggregation inhibitor (TAI) for Alzheimer?s and Behavioural variant frontotemporal dementia diseases; anti-synuclein, a synuclein protein; early-stage compounds for use in therapies for neurodegenerative diseases; and diagnostic tests that assist clinicians in detecting and confirming the nature of a disease and monitoring the effects of therapy. The company was founded by Claude Wischik in 2002 and is headquartered in Singapore. | Health Technology |
| Singapore Press Holdings Foundation Ltd. |
- Bourse
- Insiders
- Sushilan Vasoo
- Expérience
